Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?
- PMID: 17329188
- DOI: 10.1016/S1470-2045(07)70053-0
Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?
Comment on
-
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.Lancet Oncol. 2007 Mar;8(3):226-34. doi: 10.1016/S1470-2045(07)70039-6. Lancet Oncol. 2007. PMID: 17329193
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
